Announcing the new Tapestri Solution for Solid Tumor Oncology Research. Learn More ›

Home Resources Publications A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent…

FILTER RESOURCES

ALL FEATURED PUBLICATIONS SCIENTIFIC PRESENTATIONS RESEARCHER SPOTLIGHTS VIDEOS BROCHURES DATASETS USER GUIDES TECHNICAL NOTES POSTERS

publication

A JAK2/IDH1-mutant MPN clone unmasked by ivosidenib in an AML patient without antecedent MPN

Xiao, W. et al.
Blood Advances (2020)

Abstract

Myeloid neoplasm (MPN) clones can evolve from acute myeloid leukemia to gain dominance with isocitrate dehydrogenase inhibition.
Pro-differentiation agents such as ivosidenib can unmask MPN sequelae.

Authors

Xiao, W., Miles, L.A.., Bowman R.L., Durani, V., Tian H.S., DelGaudio, N.L., Mishra, T., Zhu, M. Zhang, Y., Stump, S.E.., Tallman, M.S., Levine, R.L.., Cai, S.F.

VIEW

Distinct patterns of clonal evolution drive myelodysplastic syndrome progression to secondary acute myeloid leukemia

Blood Cancer Discovery (2022)

High-throughput single-cell sequencing for retroviral reservoir characterization

scTAM-seq enables targeted high-confidence analysis of DNA methylation in single cells

Monitoring of leukemia clones in B-cell acute lymphoblastic leukemia at diagnosis and during treatment by single-cell DNA amplicon sequencing

HemaSphere (2022)